- A Pennsylvania state court jury yesterday hit Johnson & Johnson’s Janssen unit with an $8 billion punitive damages verdict over its alleged mishandling of marketing for its anti-psychotic drug Risperdal. The company is almost certain to appeal the punitive award, which is four times bigger than the next-largest U.S. verdict this year. But it still faces more than 13,000 suits over its Risperdal marketing and alleged failure to warn teens about its health risks. (BN)
- In Murray v. Janssen Pharmaceuticals, attorneys for plaintiff Nicholas Murray, who said he grew breasts after he began using Risperdal at age 9 ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.